Response Genetics Inc, Los Angeles, which provides molecular diagnostic tests that help determine a patient’s response to cancer therapy, will join the Fortified Provider Network Inc network of preferred providers, Scottsdale, Ariz .
This marks Response’s seventh health care-payor agreement this year and brings its access to more than 97 million people nationally.
Per this agreement, approximately 4.1 million members associated with more than 200 health insurers, self-funded employers, and other payors of health care services will be able to access Response Genetics’ suite of molecular predictive testing at a discounted rate.
This predictive genomic testing is targeted to patients battling lung, colon, gastric, and melanoma cancers. The results from the company’s testing services give treating physicians actionable information that enable the best therapy to be employed on that specific patient’s tumor.
[Source: Response Genetics]